[Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress]

Drugs Exp Clin Res. 1993:19 Suppl:45-53.
[Article in Italian]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use*
  • Adolescent
  • Adult
  • Anesthesia, General / adverse effects*
  • Antibody Formation / drug effects
  • Complement C3 / analysis
  • Complement C4 / analysis
  • Double-Blind Method
  • Female
  • Humans
  • Immune System / drug effects*
  • Immunologic Deficiency Syndromes / etiology
  • Immunologic Deficiency Syndromes / immunology
  • Immunologic Deficiency Syndromes / prevention & control*
  • Interleukin-2 / metabolism
  • Lymphocyte Activation / drug effects
  • Lymphocyte Subsets / drug effects
  • Lymphocyte Subsets / immunology
  • Male
  • Middle Aged
  • Neutrophils / drug effects
  • Phagocytosis / drug effects
  • Pyrrolidonecarboxylic Acid / analogs & derivatives*
  • Pyrrolidonecarboxylic Acid / pharmacology
  • Pyrrolidonecarboxylic Acid / therapeutic use
  • Respiratory Burst / drug effects
  • Stress, Physiological / etiology
  • Stress, Physiological / immunology*
  • Surgical Procedures, Operative / adverse effects*
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use*
  • Thiazolidines

Substances

  • Adjuvants, Immunologic
  • Complement C3
  • Complement C4
  • Interleukin-2
  • Thiazoles
  • Thiazolidines
  • pidotimod
  • Pyrrolidonecarboxylic Acid